In this regard, the natural compound silibin exerted hepatoprotective activity in mice with NAFLD by inhibiting ER stress and NRPL3 inflammasome activation through a SIRT2-dependent pathway [41]. Here, SIRT2 is linked to metabolic dysfunction-associated steatotic liver disease.